Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Novo’s Sogroya Now Available in Japan, Listing Came 10 Months after Approval
December 13, 2021
- Chugai’s Polivy Filed for First-Line DLBCL Treatment in Japan
December 13, 2021
- Takeda Seeks Pediatric Nod for HAE Drug Firazyr in Japan
December 13, 2021
- 7 Companies Launch E Keppra Generics upon Listing
December 13, 2021
- Authorized Generics for Edirol, Vesicare, Vegamox, and More in December Listing
December 10, 2021
- 1st Lucentis Biosimilar Launched in Japan, Senju Eyes 6.9 Billion Yen in 5th Year
December 10, 2021
- Latuda’s Use Patent Dismissed in US; Dainippon Sumitomo Plans to Appeal
December 10, 2021
- Daiichi Sankyo to Speed Up TROP2-Directed ADC Program for Breast Cancer
December 9, 2021
- Opdivo Nabs Top Slot in Japan Sales Ranking in November: Encise
December 9, 2021
- Roche/Chugai’s Tocilizumab Approved for Severe COVID-19 in Europe
December 8, 2021
- Santen Bags Global Rights to Aerie’s Glaucoma Meds, Except US, in Expanded Pact
December 8, 2021
- Shionogi’s COVID-19 Vaccine Safe and Tolerable, Increases Antibody Titers: Japan PI/II
December 8, 2021
- Sumitomo Dainippon Sets Up Subsidiary in Malaysia, Eyes Latuda Launch
December 8, 2021
- Medicago/GSK’s COVID-19 Vaccine 71% Effective: PII/III
December 8, 2021
- PI Telomelysin Trial for Esophageal Cancer Begins in US: Oncolys
December 8, 2021
- Janssen Files CAR-T Therapy Cilta-Cel for Multiple Myeloma in Japan
December 8, 2021
- EU Panel Backs Tocilizumab for Severe COVID-19: Chugai
December 8, 2021
- Japan Ethical Drug Sales Down 3.2% in October: Crecon
December 8, 2021
- Kobayashi Kako Ditches Turnaround Plan with Manufacturing Transfer to Sawai
December 7, 2021
- Horizon Plants Flag in Japan Soil to Gear Up for Thyroid Eye Disease Trial
December 7, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…